NeuroOne Medical Technologies Corporation
NMTC
$0.567
-$0.0126-2.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 153.28% | -21.07% | 3.07% | 14.64% | -6.69% |
| Total Depreciation and Amortization | 1.56% | 1.58% | 3.61% | 3.75% | -6.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -88.15% | 151.68% | -5.02% | 14.46% | 1.75% |
| Change in Net Operating Assets | -540.06% | -1,226.64% | -109.84% | 127.04% | -431.56% |
| Cash from Operations | 107.80% | -12.99% | -8.51% | 42.90% | -31.23% |
| Capital Expenditure | 33.88% | -149.32% | 52.87% | 15.36% | 35.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 33.88% | -149.32% | 52.87% | 15.36% | 25.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -50.29% | -19.62% | 66.70% | -79.19% |
| Repurchase of Common Stock | -15.31% | 79.01% | -313.27% | 16.91% | -58.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -129.01% | 2,353.15% | 37.90% | -225.46% | 95.50% |
| Cash from Financing | -120.02% | 63.02% | -20.39% | 62.67% | -76.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -103.69% | 80.37% | -230.78% | 90.68% | -217.98% |